JPET Highlight: Lyn activation and restoring glucose tolerance
Posted on 1/1/0001 12:00:00 AM
|
Tags:
MLR-1023 reduced blood glucose levels without increasing insulin secretion in vivo by allosterically activating the non-receptor linked kinase Lyn suggesting a new treatment modality for type 2 diabetes. See article atJ Pharmacol Exp Ther 2012, 342:15-22. (JPET 192096)
Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics